This security feature developed by Hyperlink Infosystem enables patients and institutions detect counterfeits. All that one needs to do is scratch the code and immediately verify this on an app or website, in no time.
With increasing instances of counterfeit products in the market it was necessary to ensure that a 100% genuine product of Zydus is available to patients. To start with the technology is being implemented in the Company's products Remdac (Remdesivir) and Virafin Inj (Pegylated Interpheron Alpha 2b) and will be seen on the product packs in the third week of June. The new feature will also be extended to other products of the company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content